Your grandparents ate it, your grandchildren will too -- but coming down from a pandemic surge in sales, Campbell Soup (NYSE: CPB), has gotten a little too cold for investors. Consumers loaded their cupboards with soup during amid lockdowns, and now that more of them are vaccinated, they're buying fewer Campbell products. The company recently reported an 11% decline in sales for the fourth quarter and projected essentially no growth for its fiscal 2022 performance.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting